Since HDAC6 KO mice do not show abnormal function of major organs [31], there may promise in developing HDAC6 inhibitors as drugs for use in the prevention and/or treatment of chronic complications like peritoneal fibrosis. This evidence concerns the gene HDAC6 and Peritoneal Fibrosis.